Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial
Intensive Care Medicine · 2023-11 · 49 (11) · 1283-1292
DOI: 10.1007/s00134-023-07208-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Intensive Care Medicine, online erschienen am 12.09.2023. Verfasst von Martin Balik und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2…. Hauptthemen laut MEDLINE: Amiodarone, Atrial Fibrillation, Shock, Septic. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Agentura Pro Zdravotnický Výzkum České Republiky.
Themen: Sepsis
Abstract (Originalsprache)
PURPOSE: Acute onset supraventricular arrhythmias can contribute to haemodynamic compromise in septic shock. Both amiodarone and propafenone are available interventions, but their clinical effects have not yet been directly compared. METHODS: In this two-centre, prospective controlled parallel group double blind trial we recruited 209 septic shock patients with new-onset arrhythmia and a left ventricular ejection fraction above 35%. The patients were randomised in a 1:1 ratio to receive either intravenous propafenone (70 mg bolus followed by 400-840 mg/24 h) or amiodarone (300 mg bolus followed by 600-1800 mg/24 h). The primary outcomes were the proportion of patients who had sinus rhythm 24 h after the start of the infusion, time to restoration of the first sinus rhythm and the proportion of patients with arrhythmia recurrence. RESULTS: Out of 209 randomized patients, 200 (96%) received the study drug. After 24 h, 77 (72.8%) and 71 (67.3%) were in sinus rhythm (p = 0.4), restored after a median of 3.7 h (95% CI 2.3-6.8) and 7.3 h (95% CI 5-11), p = 0.02, with propafenone and amiodarone, respectively. The arrhythmia recurred in 54 (52%) patients treated with propafenone and in 80 (76%) with amiodarone, p < 0.001. Patients with a dilated left atrium had better rhythm control with amiodarone (6.4 h (95% CI 3.5; 14.1) until cardioversion vs 18 h (95% CI 2.8; 24.7) in propafenone, p = 0.05). CONCLUSION: Propafenone does not provide better rhythm control at 24 h yet offers faster cardioversion with fewer arrhythmia recurrences than with amiodarone, especially in patients with a non-dilated left atrium. No differences between propafenone and amiodarone on the prespecified short- and long-term outcomes were observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 00, Prague 2, Czech Republic. martin.balik@vfn.cz.
- Department of Anesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 00, Prague 2, Czech Republic.
- Department of Anesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague, Czech Republic.
- 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Förderung
- Agentura Pro Zdravotnický Výzkum České Republiky
Zitieren
APA
Balik, M., Maly, M., Brozek, T., Rulisek, J., Porizka, M., Sachl, R., Otahal, M., Brestovansky, P., Svobodova, E., Flaksa, M., Stach, Z., Horejsek, J., Volny, L., Jurisinova, I., Novotny, A., Trachta, P., Kunstyr, J., Kopecky, P., Tencer, T., …, & Waldauf, P. (2023). Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Medicine, 49(11), 1283-1292. https://doi.org/10.1007/s00134-023-07208-3
Vancouver
Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R, et al. Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Medicine. 2023;49(11):1283-1292. doi:10.1007/s00134-023-07208-3
BibTeX
@article{Balik2023,
author = {Balik, Martin and Maly, Michal and Brozek, Tomas and Rulisek, Jan and Porizka, Michal and Sachl, Robert and Otahal, Michal and Brestovansky, Petr and Svobodova, Eva and Flaksa, Marek and Stach, Zdenek and Horejsek, Jan and Volny, Lukas and Jurisinova, Ivana and Novotny, Adam and Trachta, Pavel and Kunstyr, Jan and Kopecky, Petr and Tencer, Tomas and Pazout, Jaroslav and Belohlavek, Jan and Duska, Frantisek and Krajcova, Adela and Waldauf, Petr},
title = {Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial},
journal = {Intensive Care Medicine},
year = {2023},
volume = {49},
number = {11},
pages = {1283--1292},
doi = {10.1007/s00134-023-07208-3}
}
EUVIMED